Jerry recognizes that as car insurance premiums soar, drivers are confronted with budgeting dilemmas and are making changes ...

U.S. Attorney General Pam Bondi says she has directed federal prosecutors to seek the death penalty against Luigi Mangione, ...

The White House Correspondents’ Association has canceled plans to have comedian Amber Ruffin headline its annual fundraising dinner. The board’s decision was announced after White House deputy chief ...

CHICAGO (Reuters) -The highest dose of an experimental drug developed by Eli Lilly significantly reduced levels of a ...

Another week of escalating tariff talks led to a slump across major U.S. stock market indices for the five-day trading period. The S&P 500 dropped nearly 3% for the week, with losses in three of the ...

Hengrui Pharma signs exclusive licensing agreement for its heart disease drug with Merck & Co.

(Yicai) March 26 -- Shares of Hengrui Pharmaceuticals rose after the Chinese firm granted US-Canadian pharma giant Merck ...

Merck & Co – known as MSD outside the US and Canada – has said it will be gaining exclusive global rights to Jiangsu Hengrui ...

MRK in-licenses an experimental lipoprotein(a) inhibitor from China's Jiangsu Hengrui. This transaction is expected to be ...

Hengrui Pharma signed the agreement with Merck (NYSE: MRK) — known as MSD outside of the United States and Canada — for HRS-5346, its investigational oral small molecule Lipoprotein (a), or Lp (a), ...

MSD has entered an exclusive licence agreement with Hengrui Pharma for the oral small molecule Lp(a) inhibitor, HRS-5346.

Merck inked a $2 billion licensing deal with China’s Hengrui Pharma for exclusive rights to an experimental heart disease ...